Global Agricultural Biologicals Market to Grow at a CAGR of 12.5% During the Period 2024-2032, Driven by Growing Global Population and Demand for Advanced Food and Crop Protection Solutions

Novel innovations in sustainable agricultural biologicals, food demands of an expanding global population, rising consumer interest in environmentally-friendly solutions, weed and insect resistance to agricultural chemicals, and concerns about the environmental impact of current agricultural practices are a few factors expected to drive the global agricultural biologicals market. Demand for solutions aimed at combating abiotic stress is expected to increase. The primary markets are likely to be North America, Europe, Latin America, and Asia.

Agricultural biologicals provide growers solutions to combat resistance, improve soil health and decrease residue. Consumers have also readily adopted these solutions to enhance crop and soil health and increase production. Solution providers are consistently engaged in research and development activities to come up with advanced and innovative solutions. At the same time, companies are constantly looking to enhance their capacities and gain competitive advantages in order to increase their market share. For example, in 2020, Syngenta Crop Protection acquired Valagro, an innovation based firm engaged in biologicals, especially biostimulants. The acquisition strengthened the position of Syngenta Crop Protection in the growing biologicals market as Syngenta, with extensive research and development capabilities and an innovative biologicals portfolio, sought new commercial opportunities and greater access to global agriculture markets through the acquisition.

In 2022, Syngenta Crop Protection acquired two next generation bioinsecticides - NemaTrident® and UniSpore® - from Bionema Limited to combat increasing resistance and a variety of insects and pests across horticulture and ornamentals, turf amenity and forestry, offering customers greater choice.

In 2019, Advanced BioNutrition and GreenLight Biosciences announce a collaboration to develop high stability RNA products aimed at particular agriculture applications. Through the collaboration, the companies sought to enhance the stability and performance of RNA technology from GreenLight to fulfil rising demand from growers, consumers and the food industry for sustainable pest control solutions.

In 2022, BASF Venture Capital and Orbia Ventures invested in Israeli Biotech company FortePhest, a firm leading in nature-inspired development of novel substances. FortePhest is engaged in the development of a new technology to fight herbicide-resistant weeds and invasive plants. Inspired by natural plant processes, the company supports crop protection globally by implementing the technology that aims to resolve the challenge posed by weeds and invasive plant species.

In 2020, Gowan Company announced that its novel botanical-based fungicide - EcoSwing® - was registered for use in California. EcoSwing exhibited consistent effectiveness against major pathogens in almonds, grapes, berries, and stone fruit. Primary studies also suggested that EcoSwing could help in initiating innate plant responses to stimulate plant defence mechanisms against fungal pathogens.

In 2021, Marrone Bio Innovations, Inc. secured exclusive rights to high-performing strains of Streptomyces acidiscabies, allowing for speedy commercialization of a new, second-generation bioherbicide, MBI-006. The addition of these strains, developed by and licensed from Novozymes, would optimize MBI-006’s use rate, decrease production cost of production, and improve performance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Findings of the Report:

• Agricultural biologicals is a fast growing segment, driven by demand for food for a growing global population and innovations in sustainable agricultural biologicals. 

• Major demand for agricultural biologicals comes from food crops. 

• Constant research and development by companies and invention of new solutions are likely to drive market growth.

• North America, Europe, Latin America, and Asia are expected to be key markets.

Market Analysis by Type, Source, Application, Crop Type and Region:

• By type, the market is segmented into Bio-Pesticides, Bio-Stimulants, and Bio-Fertilizers.

• By source, the market is classified into Microbials, Biochemicals and Others.

• By application, the market is divided into Foliar Spray, Seed Treatment, Soil Treatment, and Post-Harvest.

• By crop type, the market is classified into Cereals and Grains, Oilseeds and Pulses, Fruits and Vegetables, and Others.

• By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.